Skip To Main Content
Mara Curduman on Muck Rack

Mara Curduman

As seen in: In Vivo (IIAR), UroToday
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mara

Contact Mara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Digital pathology for repeat prostate biopsy reassessment during active surveillance: an institutional experience.

|
By Ludovica Pepe, Mara Curduman, Pietro Pepe
| UroToday Verified
Repeat biopsy remains central to active surveillance (AS) because upgrading and tumor burden may change management. This retrospective paired workflow study included 38 men and 47 repeat biopsy sessions (2023-2025), comprising 846 biopsy cores and 871 H&E slides. Whole-slide imaging (WSI) and conventional microscopy were compared after a washout interval. QuPath was used only for pathologist-guided tumorlength and greatest percentage of cancer (GPC) documentation.
Open in Who Shared Issue with article?

PSMA PET/CT Accuracy in Diagnosing Prostate Cancer Nodes Metastases

|
By Pietro Pepe, Ludovica Pepe, Vincenzo Fiorentino, Mara Curduman
| In Vivo (IIAR)
Key Words: PSMA PET/CT prostate cancer nodes metastases extended PNLD Prostate cancer (PCa) treatment has been improved following a multidisciplinary approach mandatory for locally advanced or oligometastatic disease. In this respect, an accurate clinical staging is essential for planning a tailored therapy for each patient. Radical prostatectomy (RP) with or without lymphadenectomy and/or definitive radiotherapy (RT) are the main curative treatments for PCa (1).
Open in Who Shared Issue with article?
See all 2 articles